Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2004 Sep;5(5):482-9.
doi: 10.1097/01.pcc.0000128891.54799.67.

Efficacy of interventions for bronchiolitis in critically ill infants: a systematic review and meta-analysis

Caroline Davison  1 , Kathleen M Ventre, Marco Luchetti, Adrienne G Randolph
Affiliations
Meta-Analysis

Efficacy of interventions for bronchiolitis in critically ill infants: a systematic review and meta-analysis

Caroline Davison et al. Pediatr Crit Care Med. 2004 Sep.

Abstract

Background: Viral bronchiolitis is the leading cause of respiratory failure among infants in the United States. Currently, the mainstay of treatment is supportive care. The effectiveness of treatments used for mechanically ventilated infants with bronchiolitis is unclear.

Objective: To evaluate the strength of the evidence supporting the use of currently available treatments for critically ill infants with bronchiolitis.

Data source: We searched PubMed, citations of relevant articles, personal files, and conference proceedings, and we contacted experts in the field.

Study selection: Randomized, controlled trials evaluating any therapy for bronchiolitis that included children in an intensive care unit.

Data extraction: Two reviewers independently extracted data and assessed methodologic quality.

Data synthesis: A total of 2,319 citations were screened, and 16 randomized, controlled trials were included. There were three trials of surfactant, three of ribavirin, three of immune globulin, three of systemic corticosteroids, and one each of vitamin A, interferon, erythropoietin, and heliox. A meta-analysis of the three surfactant studies showed a strong trend toward a decrease in duration of mechanical ventilation of 2.58 days (95% confidence interval, -5.34 to 0.18 days; p =.07) and a significant decrease of 3.3 intensive care unit days (95% confidence interval, -6.38 to -0.23 days; p =.04). A meta-analysis of the three systemic corticosteroid studies showed no overall effect on duration of mechanical ventilation when all three trials were combined (-0.62 day; 95% confidence interval, -2.78 to 1.53 days; p =.57). We identified one published meta-analysis of three ribavirin studies showing a significant decrease in ventilator days with ribavirin (-1.2 days; 95% confidence interval, -0.2 to -3.4 days; p =.2).

Conclusions: Currently, there are no clearly effective interventions available to improve the outcome of critically ill infants with bronchiolitis. Surfactant seems to be a promising intervention, and corticosteroids or ribavirin may also be beneficial.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Meta-analysis of surfactant trials in bronchiolitis: effect on duration of mechanical ventilation. WMD, weighted mean difference; CI, confidence interval.
Figure 2
Figure 2
Meta-analysis of surfactant trials in bronchiolitis: effect on intensive care unit (ICU) length of stay. WMD, weighted mean difference; CI, confidence interval.
Figure 3
Figure 3
Meta-analysis of systemic corticosteroid trials in bronchiolitis: Effect on duration of mechanical ventilation. WMD, weighted mean difference; CI, confidence interval.
Figure 4
Figure 4
Meta-analysis of systemic corticosteroid trials in bronchiolitis: Effect on hospital length of stay. WMD, weighted mean difference; CI, confidence interval.
See this image and copyright information in PMC

Comment in

  • Bronchiolitis: what's next?
    Guerguerian AM, Farrell C, Gauthier M, Lacroix J. Guerguerian AM, et al. Pediatr Crit Care Med. 2004 Sep;5(5):498-500. doi: 10.1097/01.pcc.0000130991.23217.88. Pediatr Crit Care Med. 2004. PMID: 15356398 No abstract available.

References

    1. Law BJ, De Carvalho V. Respiratory syncytial virus infections in hospitalized Canadian children: Regional differences in patient populations and management practices. The Pediatric Investigators Collaborative Network on Infections in Canada. Pediatr Infect Dis J. 1993;12:659–663. - PubMed
    1. Hall CB. Respiratory syncytial virus and parainfluenza virus. N Engl J Med. 2001;344:1917–1928. - PubMed
    1. Shay DK, Holman RC, Newman RD, et al. Bronchiolitis-associated hospitalizations among US children, 1980–1996. JAMA. 1999;282:1440–1446. - PubMed
    1. Navas L, Wang E, de Carvalho V, et al. Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children: Pediatric Investigators Collaborative Network on Infections in Canada. J Pediatr. 1992;121:348–354. - PubMed
    1. Buckingham SC, Quasney MW, Bush AJ, et al. Respiratory syncytial virus infections in the pediatric intensive care unit: Clinical characteristics and risk factors for adverse outcomes. Pediatr Crit Care Med. 2001;2:318–323. - PubMed

MeSH terms

LinkOut - more resources